• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Ragaey, R., Abouelatta, S., Elfouly, A. (2023). Modernized Management of Ocular Keratitis via Nanovesicular Drug Delivery Systems. Journal of Advanced Pharmacy Research, 7(3), 144-162. doi: 10.21608/aprh.2023.217709.1220
Reem Ragaey; Samar Mamdouh Abouelatta; Aya Adel Elfouly. "Modernized Management of Ocular Keratitis via Nanovesicular Drug Delivery Systems". Journal of Advanced Pharmacy Research, 7, 3, 2023, 144-162. doi: 10.21608/aprh.2023.217709.1220
Ragaey, R., Abouelatta, S., Elfouly, A. (2023). 'Modernized Management of Ocular Keratitis via Nanovesicular Drug Delivery Systems', Journal of Advanced Pharmacy Research, 7(3), pp. 144-162. doi: 10.21608/aprh.2023.217709.1220
Ragaey, R., Abouelatta, S., Elfouly, A. Modernized Management of Ocular Keratitis via Nanovesicular Drug Delivery Systems. Journal of Advanced Pharmacy Research, 2023; 7(3): 144-162. doi: 10.21608/aprh.2023.217709.1220

Modernized Management of Ocular Keratitis via Nanovesicular Drug Delivery Systems

Article 3, Volume 7, Issue 3, July 2023, Page 144-162  XML PDF (507.2 K)
Document Type: Review Article
DOI: 10.21608/aprh.2023.217709.1220
View on SCiNiTO View on SCiNiTO
Authors
Reem Ragaey email 1; Samar Mamdouh Abouelatta2; Aya Adel Elfouly2
1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo, Egypt.
2Department of Pharmaceutics, Faculty of Pharmacy, Ahram Candian University, 6 October, Cairo, Egypt.
Abstract
Objective: Keratitis is considered as one of the major leading causes of blindness internationally. Briefly, it is corneal infection also termed corneal ulcer or corneal opacity. Bacterial keratitis is often a consequence of multidrug-resistant bacterial infections, which becomes unaffected by broad-spectrum antibiotics. Both, Aspergillus and Fusarium species, are the most frequent sources for mycotic keratitis. Protozoal keratitis was recently presented where best treatment results were achieved with early diagnosis. Methods: Various methods of diagnosis were adopted such as: corneal smear and corneal culture. These methods suffer from diagnostic insensitivity and being time-consuming. The Polymerase Chain Reaction is a newer, matching method used in the identification of keratitis; the findings are sample-dependent. Recently, In vivo confocal microscopy (IVCM) is an encouraging diagnostic technique of increasing significance. It is non-invasive real-time direct imagining of the microorganism and displaying infection directly in the patient's cornea. Ocular drug delivery usually suffers from low bioavailability due to various eye barriers which finally led to ineffective treatment. Results: Substantial attempts were demonstrated to enhance drug ocular bioavailability via boosting corneal diffusion and enhancing residential time. Different types of nanoparticles, liposomes, and self-emulsifying systems achieved great attention in optimizing ocular drug delivery. Nanovesicles are innovative systems with minute particle size and uniform size distribution revealing extended ocular residential time so confirming satisfactory bioavailability, less irritation, and high tolerance with ocular tissues. Conclusion: This review declares the treatment policies and highlights numerous innovative nanovesicles developed with a focus on advanced findings regarding formulation systems. 
Keywords
Keratitis; Nanovesicles; Transferosomes; Novasomes; Collagen crosslinking
Main Subjects
Section C: Drug Design, Delivery & Targeting
Statistics
Article View: 563
PDF Download: 651
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.